Abstract

• Miltenyi Biotec will be presenting the MACSima ultra-high content imaging platform
• Learn about MICS technology and how it enables hundreds of markers to be visualised from fixed tissue
• Milteyi Biotec offers thousands of validated antibodies for this but the platform is also open to 3rd party antibodies